MALI
MALI Platform
AI Stock Research

Farallon Capital Management, L.L.C.: latest 13F holdings

For the quarter ending 30 September 2026, Farallon Capital Management, L.L.C. reported 116 positions worth $23.2B in total, filed with the SEC on 16 November 2026. The quarter before, it reported $21.7B.

Read the filing at SEC EDGAR
Checked: the cover page's entry count and total value match the holdings table.
The manager was allowed to leave some positions out of this filing (confidential treatment).

Top 50 positions by value

#IssuerClassValueWeightSharesvs quarter before
1STATE STR SPDR S&P 500 ETF TTR UNIT · Put$4.0B17.15%5,220,000Cut 13.0%
2REVOLUTION MEDICINES INCCOM$2.8B11.87%13,418,796Cut 1.0%
3WARNER BROS DISCOVERY INCCOM SER A$1.5B6.58%49,372,344New
4NATERA INCCOM$1.1B4.63%2,599,648Added 17.2%
5BRIDGEBIO PHARMA INCCOM$937.5M4.04%14,247,000Added 32.6%
6PROTAGONIST THERAPEUTICS INCCOM$907.0M3.91%6,437,906Added 1.4%
7EXELIXIS INCCOM$858.3M3.70%14,694,910Added 9.1%
8ROIVANT SCIENCES LTDSHS$795.2M3.43%21,745,533Added 52.0%
9ROKU INCCOM CL A$633.5M2.73%4,160,049New
10AMAZON COM INCCOM$590.1M2.54%2,368,464Cut 10.0%
11GRAIL INCCOM$570.2M2.46%4,069,233Cut 2.2%
12BOSTON SCIENTIFIC CORPCOM$492.7M2.12%11,287,164Added 7.3%
13BROADCOM INCCOM$490.2M2.11%1,395,810Added 21.2%
14CRH PLCORD$442.2M1.91%5,341,100New
15KENVUE INCCOM$441.8M1.90%25,015,000New
16TWIST BIOSCIENCE CORPCOM$412.8M1.78%2,136,400Unchanged
17UNITEDHEALTH GROUP INCCOM$384.9M1.66%1,048,622Cut 17.5%
18MICROSOFT CORPCOM$376.2M1.62%733,563Cut 34.1%
19SYNOPSYS INCCOM$373.1M1.61%857,890Added 3.4%
20KKR & CO INCCOM$354.2M1.53%3,880,020Cut 5.8%
21AON PLCSHS CL A$343.1M1.48%1,239,672Cut 10.3%
22STRATEGY INCNOTE 12/0$328.2M1.41%—Added 310.1%
23LANTHEUS HLDGS INCCOM$309.7M1.33%3,111,254Cut 44.3%
24THERMO FISHER SCIENTIFIC INCCOM$300.9M1.30%445,685Cut 57.5%
25LIQUIDIA CORPORATIONCOM NEW$269.5M1.16%8,906,038Added 6.5%
26WABTECCOM$252.1M1.09%877,903Cut 1.9%
27BEAM THERAPEUTICS INCCOM$251.3M1.08%10,276,396Added 0.4%
28ARAMARKCOM$246.7M1.06%4,606,431Added 27.0%
29IMMUNOVANT INCCOM$218.6M0.94%6,471,000Added 11.5%
30AGIOS PHARMACEUTICALS INCCOM$197.5M0.85%5,939,400Added 0.4%
31BIOGEN INCCOM$153.8M0.66%680,868Added 859.0%
32SUPER MICRO COMPUTER INCNOTE 3.500% 3/0$151.7M0.65%—New
33JOHNSON & JOHNSONCOM$127.2M0.55%480,426Added 17.8%
34ACADIA HEALTHCARE COMPANY INCOM$126.7M0.55%4,608,400Added 9.2%
35BRIGHTSPRING HEALTH SVCS INCCOM$116.0M0.50%2,043,800Added 17.9%
36TANGO THERAPEUTICS INCCOM$113.5M0.49%4,550,688Cut 62.9%
37BAIDU INCSPON ADR REP A$104.6M0.45%1,203,785Unchanged
38AMERICAN SVGS BK NACOM$81.5M0.35%4,557,082New
39PARABILIS MEDICINES INCCOM$76.5M0.33%2,368,200Unchanged
40ASTRAZENECA PLCORD$71.0M0.31%440,000Cut 23.3%
41JOYY INCADS REPSTG COM A$65.8M0.28%820,200Added 17.3%
42AVALO THERAPEUTICS INCCOM NEW$60.9M0.26%3,974,000Added 59.1%
43FREENOME INCCOMMON STOCK$58.8M0.25%3,733,757New
44IONIC DIGITAL INCCOM CL A$57.7M0.25%718,123New
45GUARDANT HEALTH INCCOM$49.9M0.21%279,700Cut 13.2%
46STRATEGY INCNOTE 3/0$45.1M0.19%—Added 1709.7%
47ISHARES BITCOIN TRUST ETFSHS BEN INT · Put$43.4M0.19%916,800New
48ASSEMBLY BIOSCIENCES INCCOM NEW$37.7M0.16%1,604,590Unchanged
49NOVARTIS AGSPONSORED ADR$36.4M0.16%255,000Cut 29.8%
50MAZE THERAPEUTICS INCCOM$30.1M0.13%1,107,814Unchanged

Showing the largest 50 of 116 positions. Every position is in MALI's SEC Financials & 13F workspace.

New this quarter

  • WARNER BROS DISCOVERY INC · $1.5B
  • ROKU INC · $633.5M
  • CRH PLC · $442.2M
  • KENVUE INC · $441.8M
  • SUPER MICRO COMPUTER INC · $151.7M
  • AMERICAN SVGS BK NA · $81.5M
  • FREENOME INC · $58.8M
  • IONIC DIGITAL INC · $57.7M
  • ISHARES BITCOIN TRUST ETF · $43.4M

Sold out

  • ELECTRONIC ARTS INC · was $1.6B
  • CRINETICS PHARMACEUTICALS IN · was $336.4M
  • NOVO-NORDISK A S · was $125.6M
  • ISHARES TR · was $83.3M
  • VNET GROUP INC · was $46.8M
  • CG ONCOLOGY INC · was $28.4M
  • MERCK & CO INC · was $25.6M
  • WARBY PARKER INC · was $25.1M
  • PERCEPTIVE CAP SOLUTIONS COR · was $24.5M
  • AXALTA COATING SYS LTD · was $16.4M

Reading a 13F

A 13F lists a manager's long positions in US-listed securities at the end of a quarter, filed up to 45 days later. It leaves out short positions, cash and most non-US holdings, so it is a partial, delayed view of a portfolio. Nothing here is investment advice.

Positions are named as the manager filed them. Values are the filing's own, in US dollars; changes compare share counts with the quarter before.

Other managers